Staphylococcus Aureus Decolonization Study

NCT00731783 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

183

Enrollment

OTHER

Sponsor class

Conditions

Staphylococcal Skin Infections
Abscesses
Furunculosis
Staphylococcus Aureus
MRSA Infection

Interventions

DRUG: 2% Mupirocin Ointment
DRUG: 4% Chlorhexidine liquid soap
BEHAVIORAL: Hygiene protocol

Sponsor

Washington University School of Medicine